These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9114771)

  • 1. Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Take S; Matsutani M; Ueda H; Hamaguchi H; Konishi H; Baba Y; Kawaratani H; Sugiura T; Iwasaka T; Inada M
    Am J Cardiol; 1997 Apr; 79(8):1097-9. PubMed ID: 9114771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ticlopidine and cilostazol for the prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Nagaoka N; Matsubara T; Okazaki K; Masuda N; Shikaura K; Hotta A
    Jpn Heart J; 2001 Jan; 42(1):43-54. PubMed ID: 11324805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
    Tanabe Y; Ito E; Nakagawa I; Suzuki K
    Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cilostazol, a novel anti-platelet drug, on restenosis after percutaneous transluminal coronary angioplasty.
    Tsutsui M; Shimokawa H; Higuchi S; Yoshihara S; Hayashida K; Sobashima A; Kuga T; Matsuguchi T; Okamatsu S
    Jpn Circ J; 1996 Apr; 60(4):207-15. PubMed ID: 8726169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation.
    Kunishima T; Musha H; Eto F; Iwasaki T; Nagashima J; Masui Y; So T; Nakamura T; Oohama N; Murayama M
    Clin Ther; 1997; 19(5):1058-66. PubMed ID: 9385493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.
    Iida O; Yokoi H; Soga Y; Inoue N; Suzuki K; Yokoi Y; Kawasaki D; Zen K; Urasawa K; Shintani Y; Miyamoto A; Hirano K; Miyashita Y; Tsuchiya T; Shinozaki N; Nakamura M; Isshiki T; Hamasaki T; Nanto S;
    Circulation; 2013 Jun; 127(23):2307-15. PubMed ID: 23652861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cilostazol on angiographic restenosis after coronary stent placement.
    Park SW; Lee CW; Kim HS; Lee NH; Nah DY; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2000 Sep; 86(5):499-503. PubMed ID: 11009265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of cilostazol on long-term clinical outcomes after coronary stenting].
    Han YL; Wang SL; Li Y; Jing QM; Ma YY; Deng J; Yang GT; Yu HB; Ge JB
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):814-7. PubMed ID: 16316558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease.
    Ishii H; Kumada Y; Toriyama T; Aoyama T; Takahashi H; Yamada S; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1034-40. PubMed ID: 18322041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II).
    Savage MP; Goldberg S; Bove AA; Deutsch E; Vetrovec G; Macdonald RG; Bass T; Margolis JR; Whitworth HB; Taussig A
    Circulation; 1995 Dec; 92(11):3194-200. PubMed ID: 7586303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation.
    Kozuma K; Hara K; Yamasaki M; Morino Y; Ayabe S; Kuroda Y; Tanabe K; Ikari Y; Tamura T
    Am Heart J; 2001 Jan; 141(1):124-30. PubMed ID: 11136497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
    Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis.
    Sekiya M; Funada J; Watanabe K; Miyagawa M; Akutsu H
    Am J Cardiol; 1998 Jul; 82(2):144-7. PubMed ID: 9678282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
    Park SW; Lee CW; Kim HS; Lee HJ; Park HK; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 1999 Sep; 84(5):511-4. PubMed ID: 10482146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cilostazol and clopidogrel after successful coronary stenting.
    Lee SW; Park SW; Hong MK; Lee CW; Kim YH; Park JH; Kang SJ; Han KH; Kim JJ; Park SJ
    Am J Cardiol; 2005 Apr; 95(7):859-62. PubMed ID: 15781016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
    Yoon Y; Shim WH; Lee DH; Pyun WB; Kim IJ; Jang Y; Cho SY
    Am J Cardiol; 1999 Dec; 84(12):1375-80. PubMed ID: 10606107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pravastatin on prevention of restenosis after successful percutaneous transluminal coronary angioplasty.
    Onaka H; Hirota Y; Kita Y; Tsuji R; Ishii K; Ishimura T; Kawamura K
    Jpn Circ J; 1994 Feb; 58(2):100-6. PubMed ID: 8196151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.